WHO suspension: Shantha says no safety issue with pentavalent vaccine
This article was originally published in Scrip
Executive Summary
Shantha Biotechnics has said that investigations conducted so far by its Q&A cell and the World Health Organization (WHO) suggest that there is "no safety issue" with its pentavalent vaccine, Shan5, procurement of which has been temporarily suspended by the WHO.